Therapeutic Use (Phase IV)

1,197 trials 558 recruiting

Filter these 1,197 trials by condition, country, sponsor and more.

Open in Search →

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Ended

2024-510729-24-00 Chronic Migrane, Migrane, Medication Overuse Headache 2022-09-01
Clinical Trial to Evaluate the Safety and Appropriateness of Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir A… Ended

2024-511951-16-00 HIV 2022-08-30
COPD - Eosinophil-guided Reduction of Inhaled Corticosteroids (COPERNICOS) Ended

2022-501035-16-01 Chronic obstructive pulmonary disease (COPD) 2022-08-23
Tramadol OIBD Ended

2022-500108-23-00 Opioid induced bowel dysfunction 2022-08-08
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 2022-08-02
Study to evaluate the efficacy and safety of switching to insulin glargine 300 U/ml from insulin glargine 100 U/ml in patients with type 2 d… Ended

2024-518403-22-00 Diabetes mellitus II 2022-06-20
Adjusted brodalumab dose compared with standard brodalumab dose in subjects with moderate-to-severe plaque psoriasis and ≥120 kg body weight… Ended

2023-509668-11-00 Moderate-to-severe plaque psoriasis and a body weight ≥ 2022-06-15
Reversal of opioid-induced respiratory depression with opioid antagonists - a pharmacokinetic pharmacodynamic modeling study in opioid naïve… Ended

2024-518041-16-00 healthy volunteers 2022-06-15
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2 Ended

2024-519691-10-00 Septic Shock 2022-05-27
Laparoskooppisen paksusuoliresektion leikkauksen jälkeisten kivunhoitomenetelmien vertailu nykytiedon valossa Ended

2024-517509-10-00 Tutkittavat tulevat paksusuoliresektiotoimenpiteeseen j 2022-05-11
Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine (ATOM) Ended

2024-517128-21-02 Migraine 2022-05-04
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended

2023-508454-26-00 Acute Ischemic Stroke 2022-05-01
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 2022-04-08
U3P study - Upadacitinib in Psoriatic Arthritis Pain Processing Ended

2024-512669-15-00 Psoriatic arthritis 2022-03-24
LOW-DOSE DOBUTAMINE INFUSION AND SINGLE-DOSE TOCILIZUMAB IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH HIGH RISK OF CARDIOGENIC SHOCK DEVELOP… Ended

2024-515999-13-00 Acute Myocardial Infarction with increased risk of Card 2022-03-13
MR-Spectroscopy: Investigating neurochemical changes in brain metabolism in migraineurs before and after CGRP-Antibody treatment – a randomi… Ended

2024-517079-19-00 migraine 2022-02-21
GliflOzin in eLderly Diabetic patiENts: A praGmatic intraclass Evaluation trial Ended

2024-518915-20-00 Type 2 diabetes mellitus 2022-02-16
Short-term effectiveness of Gabapentin versus Placebo in acute Lumbosacral Radiculalgia by herniation disc: a prospective, multicentric, ran… Ended

2024-518053-42-00 lumbosacral radiculalgia 2022-02-09
REPLACE - A multi-centre, randomised, double-blinded, placebo controlled 16-weeks study to compare the effect of hydrocortisone and placebo … Ended

2024-513822-53-00 Tertiary adrenal insufficiency 2022-02-01
FAMODREP : Interest of Famotidine in Reducing Endothelial Expression of P-selectin in Children With Sickle Cell Disease: Pilot Study, Single… Ended

2022-502144-12-00 Sickle Cell Disease 2022-01-12
A Multicentre Surveillance Study to Evaluate the Long-term Safety in Participants who Have Been Previously Treated with 177Lu-IPN01072 in an… Ended

2024-515071-35-00 Somatostatin Receptor Positive Neuroendocrine Tumours ( 2022-01-06
Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary … Ended

2024-512727-36-00 Patients with atrial fibrillation and ST-segment elevat 2021-12-21
Study for the research of predictive factors of response to Tofacitinib therapy in patients with ulcerative rectal colitis. Ended

2024-518577-34-00 Ulcerative colitis 2021-12-16
COVID-19 vaccine immunology Ended

2024-517357-27-00 COVID-19 infection 2021-12-07